| Dual MAGL and FAAH inhibitors |
2023-7-04 |
2023-7-27 |
|
| Herpes virus entry mediator proteins and methods of use thereof |
2023-3-24 |
2023-9-28 |
|
| Pyrazole magl inhibitors |
2023-3-16 |
2023-7-13 |
|
| Anti-sars-cov2 spike (s) antibodies and uses thereof |
2023-2-17 |
2023-8-24 |
|
| Nanoparticle vaccine adjuvant and methods of use thereof |
2023-1-06 |
2023-5-25 |
|
| Coronavirus spike glycoprotein with improved expression and stability |
2022-12-22 |
2023-9-14 |
|
| Genetically modified epitopes and multiepitope proteins, immunogenic … |
2022-11-07 |
2023-5-11 |
|
| Crystalline forms of a magl inhibitor |
2022-11-01 |
2023-8-24 |
|
| Methods for modulating an immune response to cancer or tumor celts |
2022-10-31 |
2023-6-08 |
|
| Compositions and methods for long-lasting germinal center responses to a … |
2022-10-19 |
2023-6-22 |
|
| Tissue resident memory cell profiles, and uses thereof in inflammatory and … |
2022-10-17 |
2023-4-20 |
|
| Engineered rabies virus glycoprotein, compositions, and methods of use thereof |
2022-10-14 |
2023-4-20 |
|
| Compositions containing coronavirus proteins and epitopes |
2022-10-14 |
2023-4-20 |
|
| Common cold coronavirus t cell epitopes, methods and uses thereof |
2022-9-07 |
2023-8-03 |
|
| Ptprs and proteoglycans in autoimmune disease |
2022-6-23 |
2022-10-13 |
|
| Combinations of flavivirus proteins, peptide sequences, epitopes, and methods … |
2022-6-15 |
2023-5-18 |
|
| Suppressive t cell populations and methods of cancer immunotherapy |
2022-6-03 |
2022-12-08 |
|
| T cell transcriptomic profiles in parkinsons disease, and methods and uses … |
2022-5-27 |
2022-12-01 |
|
| Cytomegalovirus t cell epitopes and uses thereof |
2022-5-13 |
2022-11-17 |
|
| Coronavirus t cell epitopes, megapools and uses thereof |
2022-5-12 |
2022-11-17 |
|
| Engineered arenavirus glycoprotein compositions, methods and use thereof |
2022-4-21 |
2022-10-27 |
|
| Chimeric anti-sars-cov2 nucleoprotein antibodies |
2022-4-14 |
2022-12-29 |
|
| Coronavirus t cell epitopes and uses thereof |
2022-4-11 |
2022-10-20 |
|
| Crystalline forms of magl inhibitor |
2022-3-08 |
2022-6-07 |
|
| Compositions and methods for treating renal failure |
2022-2-25 |
2022-3-17 |
|
| Angiotensin compositions and methods related thereto |
2022-2-04 |
2022-5-26 |
|
| Chimeric anti-coronavirus spike protein antibodies |
2022-1-24 |
2022-7-28 |
|
| Human monoclonal antibody human cd134 (ox40) and methods of making and using … |
2021-11-12 |
2022-3-03 |
|
| Hla class ii-restricted tcrs against the kras g12>v activating mutation |
2021-11-03 |
2022-5-12 |
|
| Chimeric anti-sars-cov2 nucleoprotein antibodies |
2021-10-21 |
2022-4-28 |
|
| Coronavirus spike glycoprotein with improved expression and stability |
2021-10-21 |
2022-4-28 |
|
| Methods of treating inflammation or neuropathic pain |
2021-9-28 |
2022-1-13 |
|
| Human apob100 epitopes, methods and uses for modulating inflammatory responses, … |
2021-9-27 |
2022-8-18 |
|
| Batf and irf4 in t cells and cancer immunotherapy |
2021-9-21 |
2022-3-31 |
|
| Methods and compositions for diagnosing and treating cancer and disease |
2021-8-18 |
2022-3-31 |
|
| Engineered arenavirus glycoprotein compositions and methods of use thereof |
2021-8-17 |
2022-2-24 |
|
| Methods for treating and preventing cytomegalovirus infection |
2021-8-06 |
2023-6-14 |
|
| Methods for treating and preventing cytomegalovirus infection |
2021-8-06 |
2023-9-21 |
|
| Broadly neutralizing binding molecules against marburgviruses |
2021-7-20 |
2023-7-27 |
|
| Methods and compositions for diagnosing and treating cancer |
2021-7-14 |
2022-1-20 |
|
| Monocyte modulation and control of tumor metastasis |
2021-7-06 |
2021-11-04 |
|
| Methods and compositions for diagnosing and treating virally-associated disease |
2021-6-11 |
2021-12-16 |
|
| Methods of use of allergen-specific t cells in allergy and asthma |
2021-6-10 |
2021-12-16 |
|
| Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) … |
2021-6-03 |
2023-6-20 |
2023-6-20 |
| Immune cell biomarkers of cardiovascular disease |
2021-5-05 |
2021-11-11 |
|
| Combinations of viral proteins, peptide sequences, epitopes, and methods and … |
2021-4-30 |
2021-11-04 |
|
| Synthesis of a monoacylglycerol lipase inhibitor |
2021-4-19 |
2023-7-18 |
2023-7-18 |
| Methods and combinations for dual targeting of tnf family members |
2021-4-01 |
2021-10-07 |
|
| Methods for treating hypotension |
2021-3-17 |
2021-4-08 |
|
| Carbamate compounds and methods of making and using same |
2021-3-08 |
2021-6-24 |
|
| Methods for treating hypotension in a patient that has received an ACE … |
2021-3-04 |
2022-1-11 |
2022-1-11 |
| Loss of tet proteins in regulatory t cells unleashes effector function |
2021-2-12 |
2021-8-19 |
|
| Coronavirus T Cell Epitopes and Uses Thereof |
2021-2-11 |
2023-9-21 |
|
| Coronavirus t cell epitopes and uses thereof |
2021-2-11 |
2021-8-19 |
|
| Methods and compositions for modulating heterochromatin dysfunction, genomic … |
2020-11-25 |
2021-6-03 |
|
| Stem cell memory t cells, methods and uses for modulating inflammatory … |
2020-11-16 |
2021-5-20 |
|
| MAGL INHIBITORS |
2020-11-13 |
2021-2-15 |
|
| CRYSTALLINE FORMS OF A MAGL INHIBITOR |
2020-11-13 |
2022-2-16 |
|
| ? ?fr?intratumoral tcells curtail anti-pd-1 treatment efficacy |
2020-7-11 |
2022-5-18 |
|
| Cell culture medium |
2020-6-19 |
2020-12-10 |
|
| Methods for administering angiotensin ii by monitoring renin levels |
2020-6-12 |
2022-9-01 |
|
| Abhd12 inhibitors and methods of making and using same |
2020-5-13 |
2020-11-19 |
|
| Pharmacophore for trail induction |
2020-3-23 |
2020-7-24 |
|
| Spirocycle compounds and methods of making and using same |
2020-2-26 |
2021-8-25 |
|
| Spirocyclic compounds and their methods of preparation and use. |
2020-2-25 |
2020-7-10 |
|
| Inhibitors of low molecular weight protein tyrosine phosphatase and uses … |
2020-2-18 |
2022-1-11 |
2022-1-11 |
| Light inhibitors for asthma, lung and airway inflammation, respiratory, … |
2020-1-29 |
2021-6-17 |
|
| Methods of treating disease with magl inhibitors |
2020-1-24 |
2020-7-30 |
|
| Immunogenic proteins and fragments thereof from allergenic mites |
2019-12-20 |
2020-4-23 |
|
| Fn14 antibodies and uses thereof |
2019-12-19 |
2022-9-15 |
|
| Glycolipids as treatment for disease |
2019-12-18 |
2020-6-25 |
|
| Pyrazole magl inhibitors |
2019-12-04 |
2022-4-28 |
|
| Methods of treating disease with magl inhibitors |
2019-11-26 |
2020-6-04 |
|
| MAGL PYRAZOLIC INHIBITORS |
2019-11-25 |
2020-1-31 |
|
| Compositions and methods of modulating inflammation |
2019-11-11 |
2020-5-22 |
|
| Il-36 antibodies and uses thereof |
2019-9-27 |
2021-12-09 |
|
| Ptprs and proteoglycans in rheumatoid arthritis |
2019-9-19 |
2021-7-28 |
|
| Methods and compositons for modulations of immune response |
2019-8-23 |
2020-2-27 |
|
| Flavivirus peptide sequences, epitopes, and methods and uses thereof |
2019-8-09 |
2020-7-30 |
|
| Methods of treating angioedema |
2019-7-18 |
2020-1-23 |
|
| Histamine-releasing factor (hrf), hrf-receptor and methods of modulating … |
2019-7-16 |
2020-11-26 |
|
| Compositions and methods for treating iron overload |
2019-7-12 |
2020-3-09 |
|
| Methods of administering hepcidin |
2019-6-14 |
2020-1-20 |
|
| Cd33 monocytes as a biomarker |
2019-6-06 |
2019-12-12 |
|
| PHARMACEUTICAL FORMULATIONS |
2019-5-16 |
2019-9-30 |
|
| MAGL INHIBITORS |
2019-5-16 |
2019-9-30 |
|
| MAGL INHIBITORS |
2019-5-16 |
2019-9-30 |
|
| MAGL INHIBITORS |
2019-5-14 |
2019-9-30 |
|
| Modulating immune response via targeting of olfactory receptor activity |
2019-4-15 |
2021-2-24 |
|
| Tissue resident memory cell profiles, and uses thereof |
2019-3-22 |
2019-12-12 |
|
| Methods of administering hepcidin |
2019-3-21 |
2019-8-08 |
|
| Inhibition of BMP signaling, compounds, compositions and uses thereof |
2019-3-14 |
2020-8-18 |
2020-8-18 |
| Compositions comprising HEPCIDIN and methods of use thereof |
2019-2-23 |
2020-1-01 |
|
| Use and production of engineered immune cells |
2018-11-21 |
2020-8-28 |
|
| Use of peptides as biomarkers in the diagnosis, confirmation and treatment of a … |
2018-10-03 |
2019-4-11 |
|
| Use of novel biomarkers in the diagnosis, confirmation, and treatment of … |
2018-10-03 |
2019-4-11 |
|
| Modulation of immune response through stimulator of interferon genes |
2018-9-25 |
2020-7-16 |
|
| Connection-based network behavioral anomaly detection system and method |
2018-9-14 |
2020-7-28 |
2020-7-28 |
| An anti-apoptotic function of pkm2 and intracellularly expressed scfv … |
2018-8-09 |
2019-2-14 |
|
| Compositions and methods for the isolation and/or generation of specific cd4+ … |
2018-8-02 |
2021-5-06 |
|